Real-World Assessment of Quality of Life in Patients with Relapsing Remitting Multiple Sclerosis Treated with Teriflunomide for Two Years: Patient-Reported Outcomes from the AURELIO Study in Greece

INTRODUCTION: Multiple sclerosis (MS) is a highly heterogeneous inflammatory disease of the central nervous system. Patient-reported outcomes (PROs) in a real-world clinical setting can provide detailed information about MS from the patient's perspective. PROs were used here to assess quality o...

Descripción completa

Detalles Bibliográficos
Autores principales: Dardiotis, Efthymios, Perpati, Georgia, Borsos, Mariann, Nikolaidis, Ioannis, Tzanetakos, Dimitrios, Deretzi, Georgia, Koutlas, Evangelos, Kilidireas, Constantinos, Mitsikostas, Dimos Dimitrios, Hadjigeorgiou, Georgios, Grigoriadis, Nikolaos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9338205/
https://www.ncbi.nlm.nih.gov/pubmed/35829919
http://dx.doi.org/10.1007/s40120-022-00384-2

Ejemplares similares

Ejemplares similares